Join to View Full Profile
601 Elmwood Ave# 704Rochester, NY 14642
Phone+1 919-613-4077
Fax+1 919-613-4077
Dr. Dent is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Michael G. DeGroote School of MedicineClass of 1990
Certifications & Licensure
NY State Medical License 2024 - 2026
NC State Medical License 2018 - 2024
Clinical Trials
- Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477) Start of enrollment: 2020 Nov 13
- STOP-HER2: Stopping Trastuzumab in HER2+ MBC Start of enrollment: 2023 Apr 19
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Prognostic value of visually and computationally-assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030).Guilherme Nader-Marta, Xiangying Chu, Satabhisa Mukhopadhyay, Vandana G Abramson, Adam Brufsky
Journal of the National Cancer Institute. 2025-10-11 - Evaluation of efficacy and safety of sequential antibody drug conjugates (ADCs) in human epidermal growth factor 2 (HER2)-negative metastatic breast cancer.Sara Nezirevic, Carey Anders, Susan Dent, Rani Bansal, Lexie Zidanyue Yang
Breast Cancer Research and Treatment. 2025-09-11 - Management of Adverse Effects of Endocrine Therapy in Early-Stage Breast Cancer: Pharmacological and Nonpharmacological Approaches.Timothy B Winslow, Alissa Huston, Ruth O'Regan, Susan Dent
Clinical Endocrinology. 2025-08-18
Authored Content
- Highlights from SABCS 2024December 2024
- Cardio-Oncology Is a Growing Subspecialty, but Where Are the OncologistsFebruary 2024
- Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast CancerDecember 2022
Press Mentions
Cancer Patients and Survivors: If Heart Health Is a Concern, Help Is AvailableFebruary 17th, 2025- Atrium Health Receives Grant to Help Researchers Uncover Signs of Heart Damage in Breast Cancer SurvivorsJuly 7th, 2022
- Professor Receives Grant to Develop Breast Cancer Therapy That Combats Drug ResistanceSeptember 20th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
